Private Equity Other Private Equity/Strategic Investments
Natco Pharma to acquire 36% stake in South Africa’s Adcock Ingram in Rs.2,100-Cr
Source Economic Times (opens in a new tab)Press Release (opens in a new tab)BSE Announcement (opens in a new tab)
Hyderabad-based, publicly-listed Nacto Pharma has acquired a 35.75% stake in South Africa drug firm Adcock Ingram for INR 2,100 crore in a cash deal.The deal enables Nacto to enter into the South African market and tap into new revenue streams.